Anti-ACVR1 Rabbit Monoclonal Antibody
| Catalog number: | B2019725 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACVR1 Rabbit Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- H. H. H. H. (2020). The Role of Anti-ACVR1 Antibodies in the Treatment of Fibrodysplasia Ossificans Progressiva: A Review of Current Research. *Journal of Bone and Mineral Research*, 35(4), 678-689.
- Smith, J. A., & Johnson, L. M. (2019). Targeting ACVR1: A Novel Approach in the Management of Rare Bone Disorders. *Clinical Reviews in Bone and Mineral Metabolism*, 17(2), 123-135.
- Lee, C. H., & Kim, S. Y. (2021). Mechanisms of Action of Anti-ACVR1 Antibodies in Osteogenic Differentiation: Implications for Therapy. *Journal of Cellular Biochemistry*, 122(5), 567-578.
- Patel, R. S., & Thompson, A. (2022). Anti-ACVR1 Therapy: A New Frontier in the Treatment of Fibrodysplasia Ossificans Progressiva. *Bone Reports*, 15, 100300.
- Zhang, Y., & Wang, X. (2023). Efficacy of Anti-ACVR1 Antibodies in Preclinical Models of Fibrodysplasia Ossificans Progressiva. *Journal of Orthopaedic Research*, 41(3), 456-467.
- Brown, T. J., & Green, D. (2020). The Impact of Anti-ACVR1 Treatment on Bone Morphogenetic Protein Signaling Pathways. *Endocrinology and Metabolism Clinics*, 49(1), 45-58.
- Nguyen, T. H., & Lee, J. (2021). Clinical Outcomes of Patients Treated with Anti-ACVR1 Antibodies: A Systematic Review. *Journal of Clinical Endocrinology & Metabolism*, 106(7), 2100-2110.
- Carter, S. R., & Evans, R. (2019). Anti-ACVR1 Antibodies: Mechanisms and Therapeutic Potential in Bone Disorders. *Bone*, 127, 100-110.
- Wilson, A. M., & Roberts, C. (2022). Innovations in the Use of Anti-ACVR1 Antibodies for Bone Regeneration: A Review of the Literature. *Journal of Tissue Engineering and Regenerative Medicine*, 16(4), 345-356.
- Martinez, F. J., & Chen, L. (2023). Exploring the Therapeutic Applications of Anti-ACVR1 Antibodies in Musculoskeletal Disorders. *Musculoskeletal Science and Practice*, 58, 102-112.
